Cerus (CERS) Cash from Discontinued Operations (2013 - 2014)
Cerus' (CERS) quarterly Cash from Discontinued Operations came in at -$9.8 million in Q1 2014, down 17.64% year-over-year from -$11.9 million in Q1 2013, and down 17.64% quarter-over-quarter from -$8.4 million in Q1 2013.
Powered by 
Analysis
Cerus (CERS) Cash from Discontinued Operations (2013 - 2014) Analysis & Trends
Cerus has disclosed Cash from Discontinued Operations across 2 years of filings, most recently posting -$9.8 million for Q1 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Cerus | 504.42 Mn | 448.16 Mn | 29.53 Mn | - |